fiercepharmaMay 09, 2019
Tag: Novartis , Saudi Arabia
Novartis may be struggling a bit in the U.S. with cancer drug launches, but it has a new market it can now explore––Saudi Arabia.
The Swiss drugmaker has signed off on a memorandum of understanding with Sudair Pharma for a technology transfer that would allow the Saudi Arabian company to produce a number of "innovative" cancer drugs in the kingdom, the Arab News reports.
Officials told the publication that Novartis had decided to produce its oncology drugs in Saudi Arabia, a country that reports cancer rates above world averages.
If will find plenty of competition there from other Western drugmakers that got there first. Pfizer two years ago opened a $50 million, 11,108 -square-meter (119,565-square-foot) manufacturing and packaging facility in the kingdom. It was slated to produce cardiovascular, pain, anti-infective, urology and neurology products.
Also in 2017, a joint venture between the United Arab Emirates-based Julphar Gulf Pharmaceutical Industries and Cigalah Group, a Saudi healthcare distributor, opened a $53 million, 75,000-square-meter (807,292-square-foot) facility in the country to make generic drugs.
Officials in Saudi Arabia pointed to Novartis’ history of developing cancer drugs, but the pharma giant has struggled a bit in the oncology area of late. Kisqali, a breast cancer treatment approvedin 2017, has struggled to gain traction against Pfizer blockbuster Ibrance and newer rival Verzenio from Eli Lilly. And Kymriah, the company’s pioneering CAR-T drug, has run into manufacturing challenges that have slowed expansion.
But there has been one notable exception. Lutathera, approved early last year to treat somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors, has done quite well.
Register as Visitor to CPhI China 2019!
-----------------------------------------------------------------------
Editor's Note:
To apply for becoming a contributor of En-CPhI.cn,
welcome to send your CV and sample works to us,
Email: Julia.Zhang@ubmsinoexpo.com.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: